Theriva Biologics, Inc.
TOVX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,359 | $6,923 | $6,971 | $829,360 |
| - Cash | $11,609 | $23,177 | $41,786 | $67,325 |
| + Debt | $1,565 | $2,154 | $1,681 | $1,527 |
| Enterprise Value | -$7,685 | -$14,100 | -$33,134 | $763,562 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$19,290 | -$21,956 | -$19,205 | -$14,187 |
| % Margin | – | – | – | – |
| Net Income | -$25,653 | -$18,349 | -$19,685 | -$14,267 |
| % Margin | – | – | – | – |
| EPS Diluted | -19.03 | -28.48 | -32.66 | -1.9 |
| % Growth | 33.2% | 12.8% | -1,618.9% | – |
| Operating Cash Flow | -$16,937 | -$18,996 | -$19,082 | -$12,890 |
| Capital Expenditures | -$1 | -$202 | -$116 | -$14 |
| Free Cash Flow | -$16,938 | -$19,198 | -$19,198 | -$12,904 |